Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States

Gastroenterology

Volumn 137, Issue 5, 2009, Pages 1680-1686

  Kim, W Ray ^a   Terrault, Norah A ^b   Pedersen, Rachel A ^c   Therneau, Terry M ^c   Edwards, Erick ^d   Hindman, Andrew A ^e   Brosgart, Carol L ^e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic College of Medicine   (United States)

^d UNITED NETWORK FOR ORGAN SHARING   (United States)

^e GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTRATION; TREND STUDY; UNITED STATES;

ADULT; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 70350089249     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.047     Document Type: Article

References (33)

1. Kim W.R., Brown Jr. R.S., Terrault N.A., et al. Burden of liver disease in the United States: summary of a workshop. Hepatology 36 (2002) 227-242
2. Kim W.R., Benson J.T., Therneau T.M., et al. Changing epidemiology of hepatitis B in a US community. Hepatology 39 (2004) 811-816
3. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006) 705-714
4. Davis G., Albright J., Cook S., et al. Projecting the future healthcare burden from hepatitis C in the United States (abstr). Hepatology 28 (1998) 390A
5. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
6. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
7. Dienstag J., Schiff E., Wright T., et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341 (1999) 1256-1263
8. Marcellin J., Chang T.-T., Lim S., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 384 (2003) 808-816
9. Hadziyannis S.J., Tassopoulos N.C., Heathcote E.J., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348 (2003) 800-807
10. Chang T.T., Gish R.G., de Man R., et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 354 (2006) 1001-1010
11. Lai C.L., Shouval D., Lok A.S., et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354 (2006) 1011-1020
12. Lai C.-L., Gane E., Liaw Y.-F., et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 357 (2007) 2576-2588
13. Marcellin P., Heathcote E.J., Buti M., et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 359 (2008) 2442-2455
14. Liaw Y.F., Sung J.J., Chow W.C., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004) 1521-1531
15. Fontana R.J., Keeffe E.B., Carey W., et al. Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transplantation 8 (2002) 433-439
16. Schiff E.R., Lai C.-L., Hadziyannis S., et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 38 (2003) 1419-1427
17. Manns M., McHutchison J., Gordon S., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
18. Fried M.W., Shiffman M.L., Reddy K.R., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
19. Poynard T., McHutchison J., Davis G.L., et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32 (2000) 1131-1137
20. Bruno S., Stroffolini T., Colombo M., et al. Sustained virological response to interferon-alfa is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 45 (2007) 579-587
21. Strader D.B., Wright T., Thomas D.L., et al., American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
22. Kim W.R., Poterucha J.J., Kremers W.K., et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 10 (2004) 968-974
23. Lucey M.R., Brown K.A., Everson G.T., et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3 (1997) 628-637
24. Kamath P.S., and Kim W.R. Model for End-stage Liver Disease (MELD). Hepatology 45 (2007) 797-805
25. Wiesner R.H., Freeman R.B., and Mulligan D.C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127 5 Suppl 1 (2004) S261-S267
26. Welch S., Chiang B., Shadday P., et al. Estimated prevalence of chronic hepatitis B in foreign-born persons living in the United States by country/region of origin (abstr). Hepatology 48 (2008) 687A
27. Everhart J.E., and Ruhl C.E. Burden of digestive diseases in the United States, part III: liver, biliary tract, and pancreas. Gastroenterology 136 (2009) 1134-1144
28. Dienstag J.L., Goldin R.D., Heathcote E.J., et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 124 (2003) 105-117
29. Alter M., Moran-Kruszon D., Nainan O., et al. The prevalence of hepatitis C virus infection in the United States. N Engl J Med 341 (1994) 556-562
30. Wise M., Bialek S., Finelli L., et al. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 47 (2008) 1128-1135
31. Anonymous. Hepatitis surveillance report 61 (2006), Centers for Disease Control and Prevention, Atlanta, GA
32. Bower W.A., Johns M., Margolis H.S., et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 102 (2007) 2459-2463
33. Lee W.M., Squires Jr. R.H., Nyberg S.L., et al. Acute liver failure: summary of a workshop. Hepatology 47 (2008) 1401-1415